Analytical Data
-
基因名
RPH3AL
- Application
-
别名
No C2 domains proteinRabphilin-3A-like protein
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UNE2
-
表达区间
1-315aa
-
分子量
50.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPH3AL, a member of the RPH3 protein family, has garnered considerable attention in recent years due to its potential roles in neuronal function and disease mechanisms. This protein is implicated in synaptic vesicle trafficking and neurotransmitter release, processes that are crucial for effective communication between neurons. Research has identified RPH3AL as a key player in the regulation of synaptic plasticity, which underlies learning and memory. Additionally, mutations or dysregulation of RPH3AL have been linked to neurodegenerative disorders and various psychiatric conditions, highlighting its relevance in neuroscience. Comparative studies across different species suggest evolutionary conservation of its function, indicating its fundamental role in brain physiology. Given the increasing prevalence of neuropsychiatric diseases globally, understanding the molecular mechanisms of RPH3AL could pave the way for novel therapeutic strategies. As such, the study of RPH3AL not only enhances our knowledge of basic neural functions but also opens avenues for addressing critical health challenges associated with neuronal dysfunction.
